Perioperative fluids: A clear road ahead?

Current Opinion in Critical Care

Volumn 19, Issue 4, 2013, Pages 353-358

  Peng, Zhi Yong ^a   Kellum, John A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

acute kidney injury; fluid resuscitation; perioperative

Indexed keywords

CALCIUM CHLORIDE PLUS POTASSIUM CHLORIDE PLUS SODIUM CHLORIDE; INFUSION FLUID; SODIUM CHLORIDE;

ANEURYSM SURGERY; AORTA ANEURYSM; COLLOID; CRYSTALLOID; FLUID BALANCE; FLUID RESUSCITATION; FLUID THERAPY; GLYCOCALYX; HUMAN; HYPERVOLEMIA; HYPOVOLEMIA; NEPHROTOXICITY; PERIOPERATIVE PERIOD; REVIEW;

EID: 84880923938     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e3283632f1f     Document Type: Review

References (38)

1. Maitland K, Kiguli S, Opoka RO, et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011; 364:2483-2495
2. Levick JR, Michel CC. Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res 2010; 87:198-210
3. O'Neill D. The right plasma volume expander. Nursing Times 2001; 97: 27-38
4. Wills BA, Nguyen MD, Ha TL, et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med 2005; 353:877-889
5. Chappell D, Westphal M, Jacob M. The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness. Curr Opin Anaesthesiol 2009; 22:155-162
6. De Backer D, Donadello K, Taccone FS, et al. Microcirculatory alterations: Potential mechanisms and implications for therapy. Ann Intensive Care 2011; 1:27
7. Hamilton MA, Cecconi M, Rhodes A. A systematic review and meta-Analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients. Anesth Analg 2011; 112:1392-1402
8. Prowle JR, Bellomo R. Fluid administration and the kidney. Curr Opin Crit Care 2010; 16:332-336
9. Shaw AD, Kellum JA. The risk of AKI in patients treated with intravenous solutions containing hydroxyethyl starch. Clin J Am Soc Nephrol 2013; 8:497-503
10. Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2013; 2:CD000567
11. Perner A, Haase N, Guttormsen A, et al., 6S Trial Group. Scandinavian Critical Care Trials Group: Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367:124-134
12. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367:1901-1911
13. Vermeulen LC, Ratko TA, Erstad BL, et al. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. Arch Intern Med 1995; 155:373-379
14. Traylor RJ, Pearl RG. Crystalloid versus colloid versus colloid: All colloids are not created equal. Anesth Analg 1996; 83:209-212
15. Bunn F, Trivedi D. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 2012; 7:CD001319
16. Finfer S, Liu B, Taylor C, et al. Resuscitation fluid use in critically ill adults: An international cross-sectional study in 391 intensive care units. Crit Care 2010; 14:R185
17. Janssen CWJ Jr. Osmotic nephrosis. A clinical and experimental investigation. Acta Chir Scand 1968; 134:481-487
18. Cittanova ML, Leblanc I, Legendre C, et al. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996; 348:1620-1622
19. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358:125-139
20. Reinhart K, Perner A, Sprung CL, et al. Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med 2012; 38:368-383
21. Mahmood A, Gosling P, Vohra RK. Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatin during aortic aneurysm surgery. Br J Surg 2007; 94:427-433
22. The SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350:2247-2256
23. SAFE Study Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group; Australian Red Cross Blood Service; George Institute for International Health. Myburgh J, Cooper DJ, Finfer S, et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 2007; 357:874-884
24. SAFE Study Investigators. Finfer S, McEvoy S, Bellomo R, et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 2011; 37:86-96
25. Awad S, Allison SP, Lobo DN. The history of 0.9% saline. Clin Nutr 2008; 27:179-188
26. Guidet B, Soni N, Della Rocca G, et al. A balanced view of balanced solutions. Crit Care 2010; 14:325
27. Scheingraber S, Rehm M, Sehmisch C, et al. Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology 1999; 90:1265-1270
28. Gheorghe C, Dadu R, Blot C, et al. Hyperchloremic metabolic acidosis following resuscitation of shock. Chest 2010; 138:1521-1522
29. Williams EL, Hildebrand KL, McCormick SA, et al. The effect of intravenous lactated Ringer's solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesth Analg 1999; 88:999-1003
30. O'Malley CM, Frumento RJ, Hardy MA, et al. A randomized, double-blind comparison of lactated Ringer's solution and 0.9% NaCl during renal transplantation. Anesth Analg 2005; 100:1518-1524
31. Yunos NM, Bellomo R, Hegarty C, et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012; 308:1566-1572
32. Chua HR, Venkatesh B, Stachowski E, et al. Plasma-Lyte 148 vs 0.9%saline for fluid resuscitation in diabetic ketoacidosis. J Crit Care 2012; 27:138-145
33. O'Dell E, Tibby SM, Durward A, et al. Hyperchloremia is the dominant cause of metabolic acidosis in the postresuscitation phase of pediatric meningococcal sepsis. Crit Care Med 2007; 35:2390-2394
34. Lobo DN, Stanga Z, Simpson JA, et al. Dilution and redistribution effects of rapid 2-l infusions of 0.9% (w/v) saline and 5% (w/v) dextrose on haematological parameters and serum biochemistry in normal subjects: A double-blind crossover study. Clin Sci (Lond) 2001; 101:173-179
35. Reid F, Lobo DN, Williams RN, et al. (Ab) normal saline and physiological Hartmann's solution: A randomized double-blind crossover study. Clin Sci (Lond) 2003; 104:17-24
36. Shaw AD, Bagshaw SM, Goldstein SL, et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg 2012; 255:821-829
37. Zhou F, Peng Z, Kellum JA. Effects of resuscitation fluids on experimental sepsis-induced acute kidney injury. Crit Care Med 2011; 38 (Suppl.):A13
38. Murugan R, Kellum JA. Fluid balance and outcome in acute kidney injury: Is fluid really the best medicine? Crit Care Med 2012; 40:1970-1972